A global network promoting objective and open debate on drug policy
Cookie policy
We use cookies to ensure we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the IDPC website. Otherwise you can change your cookie settings here.
The main objective of the report is to inform the harm reduction strategy for Clondalkin, Ireland, to inform strategies to preventing blood borne virus transmission among the people who use drugs.
These scenarios are stories about what 'could' happen in the future in and around the hemispheric drug system, based on current trends, and including relevant political, economic, social, cultural and international dynamics.
This document aims to share experiences and strengthen programming among vulnerable adolescents in Central and Eastern Europe and the Commonwealth of Independent States.
LEAHN launched a statement of support at the UN Commission on Crime Prevention and Criminal Justice in Vienna gathering over 4,000 signatures in favour of harm reduction.
The bill needs to make it clear that its objective is to promote harm-reduction and health, as well as the decriminalisation of drug possesion for personal use.
A harm reduction approach should include friendly and objective information regarding different substances that are usually consumed via methods other than injecting.
The report documents the failing role that current federal drug policies play in supporting safety and health and draws attention to the acute need for an improved system of supports for people who inject drugs.
In examining New York’s drug policies, the conference will engage with an upcoming report by DPA and The New York Academy of Medicine: Blueprint for a Public Health Safety Approach to Drug Policy.
The conference is a major gathering for those working in the field of HIV, as well as policymakers, people living with HIV and others committed to ending the epidemic.
